Cwm LLC Has $10.49 Million Holdings in Amdocs Limited $DOX

Cwm LLC raised its stake in Amdocs Limited (NASDAQ:DOXFree Report) by 0.9% in the 2nd quarter, HoldingsChannel reports. The fund owned 115,017 shares of the technology company’s stock after buying an additional 1,022 shares during the quarter. Cwm LLC’s holdings in Amdocs were worth $10,494,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Vanguard Personalized Indexing Management LLC grew its position in shares of Amdocs by 9.5% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 12,761 shares of the technology company’s stock worth $1,164,000 after buying an additional 1,104 shares during the period. Blue Trust Inc. grew its position in shares of Amdocs by 19.7% during the 2nd quarter. Blue Trust Inc. now owns 1,899 shares of the technology company’s stock worth $173,000 after buying an additional 313 shares during the period. Callan Family Office LLC grew its position in shares of Amdocs by 157.1% during the 2nd quarter. Callan Family Office LLC now owns 9,952 shares of the technology company’s stock worth $908,000 after buying an additional 6,081 shares during the period. Clear Creek Financial Management LLC grew its position in shares of Amdocs by 28.4% during the 2nd quarter. Clear Creek Financial Management LLC now owns 3,311 shares of the technology company’s stock worth $302,000 after buying an additional 732 shares during the period. Finally, Running Oak Capital LLC grew its position in shares of Amdocs by 2.1% during the 2nd quarter. Running Oak Capital LLC now owns 175,123 shares of the technology company’s stock worth $16,033,000 after buying an additional 3,572 shares during the period. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Up 2.7%

Shares of NASDAQ DOX opened at $83.66 on Wednesday. The stock has a market cap of $9.44 billion, a P/E ratio of 16.97, a P/E/G ratio of 1.36 and a beta of 0.51. The firm has a 50 day moving average price of $84.71 and a 200 day moving average price of $87.59. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. Amdocs Limited has a 52-week low of $78.61 and a 52-week high of $95.41.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The firm had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the previous year, the firm posted $1.62 earnings per share. The business’s revenue was down 8.4% on a year-over-year basis. Analysts expect that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.527 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a yield of 2.5%. Amdocs’s payout ratio is presently 42.60%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on DOX shares. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday. Wolfe Research started coverage on shares of Amdocs in a research report on Tuesday, July 8th. They set an “outperform” rating for the company. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Amdocs in a research report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $108.00.

Get Our Latest Stock Report on Amdocs

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Stories

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.